Colon Cancer Prevention by Detection of APC Gene Mutation in a Family with Attenuated Familial Adenomatous Polyposis

  • Published : 2012.10.31


Background: Genetic mutation is a significant factor in colon CA pathogenesis. Familial adenomatous polyposis (FAP) is an autosomal dominant hereditary disease characterized by multiple colorectal adenomatous polyps affecting a number of cases in the family. This report focuses on a family with attenuated familial adenomatous polyposis (AFAP) with exon 4 mutation, c.481C>T p.Q161X of the APC gene. Methods: We analyzed 20 members of a family with AFAP. Clinical and endoscopic data were collected for phenotype determination. Genetic analysis was also performed by direct sequencing of the APC gene. Result: Five patients with a phenotype of AFAP were found. Endoscopic polyposis was demonstrated among the second generation with genotype mutation of the disease (age > 50 years) consistent with delayed phenotypic adenomatous polyposis in AFAP. APC gene mutation was identified in exon 4 of the APC gene, with mutation points of c.481C>T p.Q161X. Laparoscopic subtotal colectomy was performed to prevent carcinogenesis. Conclusion: A family with attenuated familial adenomatous polyposis of APC related to exon 4 mutation, c.481C>T p.Q161X, was reported and the phenotypic finding was confirmed by endoscopic examination. Genetic mutation analysis might be advantageous in AFAP for long term colon cancer prevention and management due to subtle or asymptomatic phenotype presentation in early adulthood.


  1. Bisgaard ML, Fenger K, Bulow S, et al (1994). Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat, 3, 121-5.
  2. Burt RW, Leppert MF, Slattery ML, et al (2004). Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology, 127, 444-51.
  3. Friedl W, Aretz S (2005). Familial adenomatous polyposis: experience from a study of 1164 unrelated german polyposis patients. Hered Cancer Clin Pract, 3, 95-114.
  4. Friedl W, Caspari R, Sengteller M, et al (2001). Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut, 48, 515-21.
  5. Hanson CA, Miller JR (2005). Non-traditional roles for the Adenomatous Polyposis Coli (APC) tumor suppressor protein. Gene, 361, 1-12.
  6. Jasperson KW, Tuohy TM, Neklason DW, Burt RW (2010). Hereditary and familial colon cancer. Gastroenterology, 138, 2044-58.
  7. Kastrinos F, Stoffel EM, Balmana J, Syngal S (2007). Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis. Am J Gastroenterol, 102, 1284-90.
  8. Kim B, Giardiello FM (2011). Chemoprevention in familial adenomatous polyposis. Best Pract Res Clin Gastroenterol, 25, 607-22.
  9. Knudsen AL, Bisgaard ML, Bulow S (2003). Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer, 2, 43-55.
  10. Knudsen AL, Bulow S, Tomlinson I, et al (2010). Attenuated familial adenomatous polyposis: results from an international collaborative study. Colorectal Dis, 12, 243-9.
  11. Levin B, Lieberman DA, McFarland B, et al (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology, 134, 1570-95.
  12. Lohsiriwat V, Lohsiriwat D, Thavichaigarn P (2009). Colorectal cancer screening and surveillance: a survey among Thai general surgeons. Asian Pac J Cancer Prev, 10, 467-70.
  13. Markowitz SD, Bertagnolli MM (2009). Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med, 361, 2449-60.
  14. Sampson JR, Dolwani S, Jones S, et al (2003). Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet, 362, 39-41.
  15. Scott RJ, Meldrum C, Crooks R, et al (2001). Familial adenomatous polyposis: more evidence for disease diversity and genetic heterogeneity. Gut, 48, 508-14.
  16. Sieber OM, Lipton L, Crabtree M, et al (2003). Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med, 348, 791-9.
  17. Soravia C, Berk T, Madlensky L, et al (1998). Genotypephenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet, 62, 1290-301.
  18. van der Luijt RB, Vasen HF, Tops CM, et al (1995). APC mutation in the alternatively spliced region of exon 9 associated with late onset familial adenomatous polyposis. Hum Genet, 96, 705-10.
  19. Vasen HF, Moslein G, Alonso A, et al (2008). Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut, 57, 704-13.
  20. Yang BH, Parkin DM, Cai L, Zhang ZF (2004). Cancer burden and trends in the Asian Pacific Rim region. Asian Pac J Cancer Prev, 5, 96-117.

Cited by

  1. Evaluation of Endoscopic Characteristics of Upper Gastrointestinal Polyps in Patients with Familial Adenomatous Polyposis vol.15, pp.16, 2014,
  2. Analysis of Small Fragment Deletions of the APC gene in Chinese Patients with Familial Adenomatous Polyposis, a Precancerous Condition vol.16, pp.12, 2015,